Share Purchase Transaction

GSK plc announced on March 11, 2026, that it purchased 513,409 of its own ordinary shares through its broker, BNP Paribas SA. The purchases were made under the company's existing buyback program, with prices ranging from 2,047.00p to 2,078.00p per share, and a volume-weighted average price of 2,061.69p. These shares will be held as treasury shares. Since February 17, 2026, GSK has repurchased a total of 8,690,409 ordinary shares. Following this transaction, the company holds 248,581,503 ordinary shares in treasury, with 4,067,587,319 ordinary shares in issue. The company also confirmed that the percentage of voting rights held in treasury is 6.11%.